Details of the Drug Formulations

General Information of Drug (ID: DM1MBYQ)

• Drug Name: Ganciclovir Drug Info
• Synonyms: ganciclovir; 82410-32-0; Gancyclovir; Cytovene; Vitrasert; Hydroxyacyclovir; Ganciclovirum; Zirgan; RS-21592; Cymevene; HHEMG; Biolf 62; BW-759U; Ganciclovirum [Latin]; 2'-NDG; 2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one; BW 759U; BIOLF-62; 2'-Nor-2'-deoxyguanosine; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BW-B 759U; UNII-P9G3CKZ4P5; DRG-0018; BW 759; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; CCRIS 9212; GA2; Cytovene-IV; HSDB 6512

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Approved	[1]
Cytomegalovirus retinitis	9B72.00	Approved	[1]
Virus infection	1A24-1D9Z	Approved	[2]
Radiculitis		Investigative	[1]

• Therapeutic Class: Antiviral Agents
• Cross-matching ID:
  PubChem CID: 135398740
  ChEBI ID: CHEBI:465284
  CAS Number: 82410-32-0
  TTD ID: D05ARP
  VARIDT ID: DR00027
  ACDINA ID: D00298

Full List of Drug Formulations Containing This Drug

Ganciclovir 250 mg capsule

Company	Formulation ID	FDA Description
Ranbaxy Pharmaceuticals	F09078	Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Croscarmellose sodium; Lecithin, soybean; Povidone; Cellulose, microcrystalline; Ferric oxide black; Gelatin; Shellac

Ganciclovir 500 mg capsule

Company	Formulation ID	FDA Description
Ranbaxy Pharmaceuticals	F09079	Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Croscarmellose sodium; Lecithin, soybean; Povidone; Cellulose, microcrystalline; Ferric oxide black; Gelatin; Shellac

Ganciclovir Sodium eq 500mg base/vial injectable

Company	Formulation ID	FDA Description
Fresenius Kabi Usa ; H2-Pharma ; Pharmascience	F24244	Hydrochloric Acid; Sodium Hydroxide

References

• [1] Ganciclovir FDA Label
• [2] Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.